Mylan Expects Competition From Duragesic “Authorized” Generic In January
This article was originally published in The Pink Sheet Daily
Executive Summary
Mylan’s guidance assumes a Jan. 24 launch of its fentanyl generic “with at least one competitor in the market.” Watson says it anticipates a 2005 launch for its generic.